Stevanato Group (NYSE:STVN) Trading Up 4.9% – What’s Next?

Stevanato Group S.p.A. (NYSE:STVN)’s stock price traded up 4.9% during mid-day trading on Tuesday . The stock traded as high as €22.97 ($23.93) and last traded at €22.61 ($23.55). 235,373 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 498,169 shares. The stock had previously closed at €21.55 ($22.45).

Wall Street Analyst Weigh In

Several research analysts have issued reports on STVN shares. Wolfe Research initiated coverage on shares of Stevanato Group in a report on Friday, December 13th. They set an “outperform” rating and a $28.00 target price on the stock. Bank of America lifted their price target on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, December 13th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of €28.60 ($29.79).

Stevanato Group Stock Performance

The firm has a 50 day moving average price of €20.40 and a 200-day moving average price of €19.89. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The firm has a market capitalization of $6.72 billion, a price-to-earnings ratio of 48.40, a PEG ratio of 10.49 and a beta of 0.59.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.16 EPS. As a group, sell-side analysts expect that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Hardy Reed LLC increased its position in shares of Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after acquiring an additional 840 shares during the last quarter. Lindenwold Advisors INC lifted its holdings in Stevanato Group by 13.5% during the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock worth $239,000 after buying an additional 1,415 shares during the last quarter. Captrust Financial Advisors grew its position in shares of Stevanato Group by 12.7% in the 3rd quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock worth $262,000 after acquiring an additional 1,480 shares in the last quarter. Raymond James Trust N.A. raised its position in shares of Stevanato Group by 22.6% during the 3rd quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock valued at $251,000 after acquiring an additional 2,317 shares in the last quarter. Finally, First Bank & Trust lifted its stake in Stevanato Group by 29.1% during the third quarter. First Bank & Trust now owns 14,109 shares of the company’s stock worth $282,000 after purchasing an additional 3,182 shares during the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.